Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zai Lab (ZLAB) EBT (2020 - 2025)

Zai Lab's EBT history spans 6 years, with the latest figure at -$53.3 million for Q4 2025.

  • For Q4 2025, EBT rose 34.7% year-over-year to -$53.3 million; the TTM value through Dec 2025 reached -$178.5 million, up 30.59%, while the annual FY2025 figure was -$178.5 million, 30.59% up from the prior year.
  • EBT for Q4 2025 was -$53.3 million at Zai Lab, down from -$36.0 million in the prior quarter.
  • Across five years, EBT topped out at -$36.0 million in Q3 2025 and bottomed at -$233.1 million in Q1 2021.
  • The 5-year median for EBT is -$81.0 million (2024), against an average of -$95.8 million.
  • The largest annual shift saw EBT plummeted 387.15% in 2021 before it soared 70.77% in 2022.
  • A 5-year view of EBT shows it stood at -$211.3 million in 2021, then skyrocketed by 70.77% to -$61.8 million in 2022, then plummeted by 54.49% to -$95.4 million in 2023, then grew by 14.4% to -$81.7 million in 2024, then surged by 34.7% to -$53.3 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's EBT are -$53.3 million (Q4 2025), -$36.0 million (Q3 2025), and -$40.7 million (Q2 2025).